Ideaya Biosciences Inc (NASDAQ: IDYA) open the trading on Thursday, with a bit cautious approach as it glided -4.45% to $28.15, before settling in for the price of $29.46 at the close. Taking a more long-term approach, IDYA posted a 52-week range of $25.54-$47.74.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The Healthcare Sector giants’ yearly sales growth during the last 5-year period was 14.24%. Meanwhile, its Annual Earning per share during the time was -2.95%. Nevertheless, stock’s Earnings Per Share (EPS) this year is -27.68%. This publicly-traded company’s shares outstanding now amounts to $84.48 million, simultaneously with a float of $76.56 million. The organization now has a market capitalization sitting at $2.38 billion. At the time of writing, stock’s 50-day Moving Average stood at $33.34, while the 200-day Moving Average is $39.16.
Ideaya Biosciences Inc (IDYA) Ownership Facts and Figures
Sometimes it helps to make our mind if we keep our tabs on how bigger investors are working with the stock of the Biotechnology industry. Ideaya Biosciences Inc’s current insider ownership accounts for 9.37%, in contrast to 92.02% institutional ownership. Preceding that transaction, on May 29 ’24, Company’s Chief Scientific Officer sold 28,500 for 36.24, making the whole transaction’s value amount to 1,032,884. This particular insider is now the holder of 0 in total.
Ideaya Biosciences Inc (IDYA) Earnings and Revenue Records
Ideaya Biosciences Inc’s EPS decrease for this current 12-month fiscal period is -27.68% and is forecasted to reach -2.75 in the upcoming year.
Ideaya Biosciences Inc (NASDAQ: IDYA) Trading Performance Indicators
Let’s observe the current performance indicators for Ideaya Biosciences Inc (IDYA). It’s Quick Ratio in the last reported quarter now stands at 17.50. The Stock has managed to achieve an average true range (ATR) of 1.32. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 198.84.
In the same vein, IDYA’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -2.18, a figure that is expected to reach -0.62 in the next quarter, and analysts are predicting that it will be -2.75 at the market close of one year from today.
Technical Analysis of Ideaya Biosciences Inc (IDYA)
[Ideaya Biosciences Inc, IDYA] recent stats showed that its last 5-days Average volume was poorer than the volume it posted in the year-ago period. During the previous 9 days, stock’s Stochastic %D was recorded 31.96% While, its Average True Range was 1.27.
Raw Stochastic average of Ideaya Biosciences Inc (IDYA) in the period of the previous 100 days is set at 0.31%, which indicates a major fall in contrast to 1.47% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 26.50% that was lower than 50.37% volatility it exhibited in the past 100-days period.
